| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/24/1998 | WO1998041628A1 Secreted salivary zsig32 polypeptides |
| 09/24/1998 | WO1998041627A1 Secreted polypeptides with homology to xenopus cement gland proteins |
| 09/24/1998 | WO1998041626A1 A NOVEL Bak BINDING PROTEIN, DNA ENCODING THE PROTEIN, AND METHODS OF USE THEREOF |
| 09/24/1998 | WO1998041625A1 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection |
| 09/24/1998 | WO1998041624A1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 09/24/1998 | WO1998041616A1 Mammalian alcohol dehydrogenase and aldehyde dehydrogenase production in plants |
| 09/24/1998 | WO1998041562A1 Non-antigenic branched polymer conjugates |
| 09/24/1998 | WO1998041542A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 09/24/1998 | WO1998041541A1 Therapeutic uses of grip and grip-related molecules |
| 09/24/1998 | WO1998041539A2 Secreted proteins and polynucleotides encoding them |
| 09/24/1998 | WO1998041538A2 Novel human cytokine/steroid receptor protein |
| 09/24/1998 | WO1998041535A2 Activation of peptides |
| 09/24/1998 | WO1998041533A1 An embcab operon of mycobacteria and mutants thereof |
| 09/24/1998 | WO1998041240A1 Methods and compositions for use in gene therapy for treatment of hemophilia |
| 09/24/1998 | WO1998041238A2 Methods and kits for treating and diagnosing leiomyomas |
| 09/24/1998 | WO1998041236A1 Pharmaceutical composition for eliminating membrane-mediated cell resistance |
| 09/24/1998 | WO1998041235A1 Use of avian antibodies |
| 09/24/1998 | WO1998041234A1 Novel compounds |
| 09/24/1998 | WO1998041233A1 Novel compounds |
| 09/24/1998 | WO1998041232A2 Compositions for modulating responsiveness to corticosteroids |
| 09/24/1998 | WO1998041231A1 Suppression of malignancy utilizing ribonucleotide reductase r1 |
| 09/24/1998 | WO1998041230A1 Preventive and/or therapeutic agent for cachexia |
| 09/24/1998 | WO1998041229A1 USE OF IL-12p40 AS IMMUNOSTIMULANT |
| 09/24/1998 | WO1998041228A1 Transmucosal induction of tolerance to parenterally administered non-autologous polypeptides |
| 09/24/1998 | WO1998041227A1 Hgf for treating acute renal failure |
| 09/24/1998 | WO1998041226A1 Pharmaceutical combined preparations containing erythropoietin and iron preparations |
| 09/24/1998 | WO1998041225A1 Pharmaceutical compositions |
| 09/24/1998 | WO1998041224A1 Use of protegrins for periodontal indications |
| 09/24/1998 | WO1998041223A1 N-methyl-d-aspartate receptor channel blockers and method for identifying such |
| 09/24/1998 | WO1998041222A1 Obesity protein formulations |
| 09/24/1998 | WO1998041220A1 Mononuclear phagocytes and their use to promote axonal regeneration |
| 09/24/1998 | WO1998041204A1 Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemo- and radiotherapy |
| 09/24/1998 | WO1998041193A1 Preparation of powder agglomerates |
| 09/24/1998 | WO1998041188A2 Stable particle in liquid formulations |
| 09/24/1998 | WO1998041090A1 Methods and compositions for stimulating apoptosis and cell death or for inhibiting cell growth and cell attachment |
| 09/24/1998 | DE19713434C1 Protein zur Inhibierung von Apoptose Protein for the inhibition of apoptosis |
| 09/24/1998 | DE19711795A1 Use of cyclosporin as immuno-modulator to treat myocardial infarction and its after-effects |
| 09/24/1998 | CA2644454A1 Death domain containing receptor 5 |
| 09/24/1998 | CA2285701A1 .beta.-catenin, tcf-4, and apc interact to prevent cancer |
| 09/24/1998 | CA2284109A1 Secreted proteins and polynucleotides encoding them |
| 09/24/1998 | CA2284108A1 Novel human cytokine/steroid receptor protein |
| 09/24/1998 | CA2284062A1 Transmucosal induction of tolerance to parenterally administered non-autologous polypeptides |
| 09/24/1998 | CA2284039A1 Methods and kits for treating and diagnosing leiomyomas |
| 09/24/1998 | CA2283901A1 Pharmaceutical compositions |
| 09/24/1998 | CA2283891A1 Mononuclear phagocytes and their use to promote axonal regeneration |
| 09/24/1998 | CA2283737A1 Human tumorigenesis associated protein, htap |
| 09/24/1998 | CA2283690A1 Human tumor suppressor |
| 09/24/1998 | CA2283688A1 Serine/threonine protein kinase |
| 09/24/1998 | CA2283674A1 Human pancreatitis-associated protein, pap-2 |
| 09/24/1998 | CA2283639A1 Methods and compositions for use in gene therapy for treatment of hemophilia |
| 09/24/1998 | CA2282845A1 Methods and compositions for modulating responsiveness to corticosteroids |
| 09/24/1998 | CA2281738A1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 09/24/1998 | CA2253629A1 Agent for preventing and/or treating cachexia |
| 09/23/1998 | EP0866131A2 Humanized anti-human fas antibody |
| 09/23/1998 | EP0866130A1 CHO cell sialidase by recombinant DNA technology |
| 09/23/1998 | EP0866128A2 Recombinant ricin toxin |
| 09/23/1998 | EP0866127A2 HE8AN36, a steroid hormone receptor homolog |
| 09/23/1998 | EP0866126A1 CDNA clone HNFDY20 that encodes a novel human 7-transmembrane receptor |
| 09/23/1998 | EP0866125A1 Novel protein hmw human mp52 |
| 09/23/1998 | EP0866124A2 Composition containing a compound modifying directly or indirectly the activity of endogenous T1-M protein |
| 09/23/1998 | EP0866075A2 Method to treat microbial infections by uncoupling of phosphotransferase system and appropriate agents therefor |
| 09/23/1998 | EP0866074A1 Novel nk374186 analogues or pharmacologically acceptable salts thereof |
| 09/23/1998 | EP0865792A1 Pharmaceutical composition containing immunoglobulin for topical use |
| 09/23/1998 | EP0865499A1 Production of lysosomal enzymes in plant-based expression systems |
| 09/23/1998 | EP0865492A1 Specific binding members for human carcinoembryonic antigen, materials and methods |
| 09/23/1998 | EP0865491A1 Compounds having lectin properties and biological uses thereof |
| 09/23/1998 | EP0865490A1 Dna sequence encoding the tumor suppressor ing1 |
| 09/23/1998 | EP0865489A1 Modified vegf antisense oligonucleotides |
| 09/23/1998 | EP0865483A2 SIGNALING INOSITOL POLYPHOSPHATE 5-PHOSPHATASES (SIPs) |
| 09/23/1998 | EP0865448A1 Apoptosis induced by monoclonal antibody anti-her2 |
| 09/23/1998 | EP0865447A1 Cyclic dodecapeptide and process for the preparation thereof |
| 09/23/1998 | EP0865446A1 Agents for promoting bone formation |
| 09/23/1998 | EP0865339A1 Metalloproteinase inhibitors |
| 09/23/1998 | EP0865298A1 Drug therapy |
| 09/23/1998 | EP0865295A1 Use of human chorionic gonadotropin in the treatment of kaposi's sarcoma |
| 09/23/1998 | EP0865294A1 Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions |
| 09/23/1998 | EP0865293A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 09/23/1998 | EP0865292A1 Compositions and methods for the prevention and treatment of oral mucositis |
| 09/23/1998 | EP0865291A1 Localized intravascular delivery of tfpi for inhibition of restenosis in recanalized blood vessels |
| 09/23/1998 | EP0865288A2 Bioartificial devices and cellular matrices therefor |
| 09/23/1998 | EP0865282A1 Chimeric antiviral agents which incorporate rev binding nucleic acides |
| 09/23/1998 | EP0764169B1 Drug salts |
| 09/23/1998 | EP0749481B1 Humanized monoclonal antibodies against human interleukin-4 |
| 09/23/1998 | EP0678100B1 Synthetic amphipathic peptides with antimicrobial activity |
| 09/23/1998 | EP0651810B1 K. lactis pyruvate-decarboxylase promoter gene and use thereof |
| 09/23/1998 | EP0627002B1 Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
| 09/23/1998 | EP0604418B1 Isolated viral protein cytokine antagonists |
| 09/23/1998 | CN1194009A 结肠特异性基因及蛋白质 Colon-specific genes and proteins |
| 09/23/1998 | CN1194001A Neutralizing conformational epitopes of chicken anemia virus |
| 09/23/1998 | CN1194000A Methods for enhancement of protective immune responses |
| 09/23/1998 | CN1193980A G-protein receptor HTNAD 29 |
| 09/23/1998 | CN1193979A Macrolides |
| 09/23/1998 | CN1193978A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 09/23/1998 | CN1193977A Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin |
| 09/23/1998 | CN1193915A Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
| 09/23/1998 | CN1193914A Method of preventing TPO adsorption and stable TPO containing composition |
| 09/23/1998 | CN1193907A Preparation and methods for the treatment of T cell mediated diseases |
| 09/23/1998 | CN1193889A Peptides derived from human heat shock protein 60 for treatment of diabetes, compositions methods and kits |
| 09/22/1998 | US5811654 Plants genetically enhanced for nutritional quality |
| 09/22/1998 | US5811548 Tri-and tetracyclic compounds |